Pioneering Fertility Preservation: The 1998 Breakthrough That Changed Everything
Today, egg freezing (oocyte cryopreservation) is a standard fertility option, empowering women to preserve their fertility for medical or social reasons. But just two decades ago, the concept was considered highly experimental—physically possible in a lab, but rarely successful in creating a baby.
In the late 1990s, the field of reproductive medicine faced a biological wall: the human egg. Unlike embryos, which had been successfully frozen since the 1980s, the unfertilized egg is a massive cell filled with water. When subjected to the “slow freezing” techniques of the time, this water often turned into jagged ice crystals, destroying the delicate meiotic spindle and rendering the egg useless.
In 1998, Dr. Andrea Vidali helped break that wall.
Presented as a conference abstract in Fertility and Sterility, Dr. Vidali’s research was one of the earliest large-scale series to demonstrate that frozen eggs could actually result in viable pregnancies. This work moved the needle from “theoretical” to “clinical reality.”
The Context: A “Frozen” Stalemate
In 1998, patients who had extra eggs during IVF faced a difficult choice: fertilize them all and freeze the embryos, or discard them. For patients with ethical or religious objections to freezing embryos, there was no option.
Dr. Vidali and his colleagues at Columbia University and RAPRUI International (Rome) sought to prove that freezing the unfertilized egg was a viable alternative.
The Breakthrough
This study was groundbreaking not just for its intent, but for its sheer volume in an era when most egg freezing studies involved mice or single case reports.
-
The Technique: Before the modern era of “Vitrification” (flash freezing), this team utilized a modified slow-freeze protocol using propanediol and sucrose to protect the cell.
-
The Results: The study followed 62 couples. Most importantly, it achieved a 17% clinical pregnancy rate per transfer. While modest by today’s standards, in 1998, this was a revolutionary proof of concept.
The Legacy
This paper is a cornerstone in the history of fertility preservation. By proving that human oocytes could survive the thaw, be fertilized via ICSI, and result in live births, Dr. Vidali’s work laid the foundation for the widespread adoption of egg freezing we see today.
Archived Research: The Original 1998 Abstract
The following is the raw text of the original abstract presented by Dr. Andrea Vidali and colleagues in 1998. It remains a critical document in the history of reproductive medicine.
Oocyte cryopreservation is a viable alternative option for patients who refuse embryo freezing.
Authors: A. Vidali, G. Dani, M. Antinori, F. Cerusico, C. Versaci, M. V. Sauer, S. Antinori. Columbia University and CHR, New York, N.Y. and RAPRUI International Associated Research for Human Reproduction Infertility Unit, Rome, Italy.
Objective: To assess the success of freezing metaphase II oocytes for the purpose of banking for future use in women who, for ethical or religious reasons, are unwilling to cryopreserve embryos.
Methods: Couples (n=62) undergoing IVF were offered oocyte freezing as an alternative to traditional embryo freezing. Metaphase II oocytes were stripped of the cumulus and frozen using 1,2-propanediol (1.5%) and 1,2-propanediol (1.5%) plus sucrose (0.1%) as cryoprotectants in a long freezing protocol. Indication for freezing included: ethical/religious 87%, inability to produce a sperm sample 6.5%, severe ovarian hyperstimulation 6.5%. Mean patient age was 27.2+3.7 yrs., average number of oocytes retrieved 20.8+3.2 per recipient.
Results: To date 48 couples have undergone frozen thaw cycles. A total of 471 oocytes were thawed. Post thaw survival was 62.5+0.2%. Fertilization rate was 56+0.2%. Average number of embryos transferred 3.0+2.1 per ET. Clinical pregnancy per initiated cycle was 12.5%. Clinical pregnancy per transfer was 17%. Ongoing/delivered pregnancy was 7% per transfer. Of the subgroup of patient (n=8) who had all oocytes cryopreserved 5 clinical pregnancies were observed. Of these 5 pregnancies 2 are delivered while 3 spontaneously aborted.
Conclusions: Oocyte cryopreservation followed by ICSI represents a viable option for patients who for moral or religious reasons do not desire embryo cryopreservation. This indication may also be extended to patients who for personal or medical reasons desire to postpone fertility.
